Cytotoxics derived from distamycin A and congeners

Current Pharmaceutical Design

Volumn 4, Issue 3, 1998, Pages 181-201

  Cozzi, P ^a   Mongelli, N ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; CONGOCIDINE; DISTAMYCIN A; DISTAMYCIN A DERIVATIVE; LEXITROPSIN; LEXITROPSIN DERIVATIVE; MEN 10710; TALLIMUSTINE; TALLIMUSTINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER; CONTROLLED STUDY; DNA ALKYLATION; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG MECHANISM; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA L 1210; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOSARCOMA; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0031836173     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Arcamone, F.; Penco, S , Drezzi, P. G., Nicolella, V ; Pirelli, A. Nature, 1964, 203, 1064
2. Arcamone, F.; Orezzi, P. G.; Barbieri, W ; Nicolella, V.; Penco, S. Gazz. Chim. Ital , 1967, 97, 1097
3. Julia, M.; Preau-Joseph, N. Compt.Rend., 1963, 257, 1115.
4. Probst, G.W ; Hoehn, M.M.; Woods, B L. Antimicrob. Agents Chemother., 1965, 789.
5. Penco, S.; Redaelli, S.; Arcamone, F. Gazz. Chim. Ital., 1967, 97, 1110.
6. Bialer, M.; Yagen, B., Mechoulam, R. Tetrahedron, 1978, 34, 2389.
7. Grehn, L.; Ragarsson, U. J. Org. Chem. 1981, 46, 3492.
8. ] Di Marco, A.; Gaetani, M ; Orezzi, P.; Scotti, T.; Arcamone, F. Cancer Chemotherapy Reports, 1962, 18, 15.
9. Hahn, F.E. in Antibiotics III : Mechanism of action of antimicrobial and antitumor agents; J.W. Corcoran, F.E Hahn Eds.; Springer Verlag; New York, 1975, p 79.
10. Bialer, M. in : Antiviral drugs and interferon. The molecular basis of their activity , Y. Becker Ed. ; Martinus Nyoff; Boston, 1984, p.143.
11. Lee, S.; Inselburg, J J. Parasitol.,1993, 79, 780.
12. Borowy-Borowski, H.; Lipman, R.; Tomasz, M Biochemistry, 1990, 29, 2999.
13. Kopka, M.L.; Goodsell, D.S.; Baikalov, I.; Grzeskowiak, K., Cascio, D.; Dickerson, R E. Biochemistry, 1994, 33, 13593.
14. Reynolds, V.L.; McGovren, J.P.; Hurley, L.H. J. Antibiotics, 1986 , 39, 319.
15. Aristoff, P.A. in Advances in Medicinal Chemistry, JAI Press, 1993, Vol.2, p.67
16. Kobayashi, E ; Okamoto, A.; Asada, M.; Okabe, M.; Nagamura, S.; Asai, A.; Saito, H.; Gomi, K.; Hirata, T. Cancer Res., 1994, 54, 2404.
17. Zein, N.; Sinha, A M ; McGahren W.J.; Ellestad, G.A Science, 1988, 240, 1198.
18. Kenani, A ; Lohez, M.; Houssin, R ; Helbecque, N.; Lemay, P.; Henichart, J P. Anti-Cancer Drug Design, 1987, 2, 47.
19. Chen, A.Y.; Yu, C.; Gatto, B.; Liu, L.F. Proc. Nat. Acad. Sci. USA, 1993, 37, 8131.
20. Chen, A.Y.; Liu, L F Annu. Rev. Pharmacol Toxicol , 1994, 34, 191.
21. Kapuscinski, J.; Szer, W. Nucleic Acids Res., 1979, 6, 3519
22. Brown, D.G ; Sanderson, M.R.; Skelly, J V.; Jenkins, T.C ; Brown, T.; Gasman, E.; Stuart, D.I.; Niedle, S. EMBO J., 1990, 9, 1329.
23. Cory, M.; Tidwell, R.R.; Farley, A.T. J. Med. Chem., 1992, 35, 431.
24. Ginsburg, H.; Nissani, E.; Krugliak, M.; Williamson, D.H. Mol. Biochem. Parasitol., 1993, 58, 7.
25. Zunino, F ; Animati, F.; Capranico, G. Curr. Pharm. Design, 1995, 1, 83.
26. Pindur, U.; Fischer, G Curr. Med Chem., 1996, 3, 379.
27. D'Incalci, M.; Sessa, C. Exp Opin. Invest Drugs, 1997, 6, 875
28. Baguley, B.C. Cell Mol. Biochem., 1982, 43, 167.
29. Kopka, M.; Yoon, C , Goodsell, D.; Piura, P ; Dickerson, R E Proc. Nat Acad. Sci. USA, 1985, 82, 1376
30. D'Alessio, R ; Geroni, C ; Biasoli, G.; Pesenti, E.; Grandi, M ; Mongelli, N. Bioorg. Med. Chem Lett.,1994, 4, 1467
31. Youngquist, R.S.; Dervan P.B. Proc. Nat Acad. Sci. USA, 1985, 82, 2565.
32. Dervan, P.B. Science, 1986, 232, 464.
33. Taylor, J.S.; Schultz, P.G.; Dervan, P.B Tetrahedron, 1984, 40, 457
34. Arcamone, F , Mongelli, N.; Animati, F. Patent GB 2178037A, 1987
35. Baker, B.F., Dervan, P.B. J.Am. Chem. Soc.,1985, 107, 8266.
36. Krowicki, K.; Balzarini, J.; De Clercq, E.; Newman, R A.; Lown, J.W. J Med. Chem. 1988, 31, 341
37. Arcamone, F.; Animati, F., Barbieri, B.; Configliacchi, E.; D'Alessio, R., Geroni, C.; Giuliani, F ; Lazzari, E.; Menozzi, M.; Mongelli, N.; Penco, S.; Verini, M.A. J. Med. Chem., 1989, 32,774.
38. Bardos, T J , Datta-Gupta, N.; Hebborn, P.; Triggle, D.J. J Med Chem., 1965, 8, 167
39. Pezzoni, G., Grandi, M ; Biasoli, G.; Capolongo, L.; Ballinari, D.; Giuliani, F.C.; Barbieri, B.; Pastori, A ; Pesenti, E.; Mongelli, N.; Spreafico, F. Br. J. Cancer, 1991, 64,1047.
40. Hageboutros, A , Mooneyham, A.; De Maria, T.; VonHoff, D.; Vitek, L.; O'Dwyer, P.J.; Weiss, G.R. Proceedings Am. Assoc. Cancer. Res., 1994, 35, 246.
41. Punt, C J A.; Humblet, Y.; Roca, E. Dirix, L.J.; Wainstein, R.; Polli, A., Corradino, I. Br. J. Cancer, 1996, 73, 803.
42. Viallet, J.; Stewart, D., Shepherd, F.; Ayoub, J.; Cormier, Y.; Di Pietro, N.; Steward, W. Lung Cancer, 1996, 15, 367.
43. R & D focus, 1997, X97-02287.
44. Broggini, M.; Ponti, M.; Ottolenghi, S.; D'Incalci, M., Mongelli, N , Mantovani, R Nucleic Acids Res., 1989, 17, 1051.
45. Broggini, M.; Erba, E.; Ponti, M.; Ballinari, D.; Geroni, C.; Spreafico, F ; D'Incalci, M.; Cancel Res. 1991, 51, 199.
46. Broggini, M.; Coley, H.L , Mongelli, N.; Pesenti, E ; Wyatt, M D.; Hartley, J.A.; D'Incalci, M. Nucleic Acids Res., 1995, 23, 81.
47. Beccaglia, P.; Grimaldi, K.A.; Hartley, J.A.; Marchini, S.; Broggini, M.; D'Incalci, M. Br. J Cancer, 1996, 73 (Supp. XXVI),12.
48. Ragg, E.; Mazzini, S , Bortolini, R.; Mongelli, N.; D'Alessio, R. J. Chem. Soc. Perkin 2, 1998, 149.
49. Ghielmini, M.; Bosshard, G.; Capolongo, L., Geroni, C.; Pesenti, E ; Torri, V.; D'Incalci, M ; Cavalli, F.; Sessa, C. Brit. J. Cancer, 1997, 75, 878.
50. Lown, J.W.; Krowicki, K.; Bhat, U.G.; Skorobogaty, A.; Ward, B.; Dabrowiak, J.C Biochemistry, 1986, 25, 7406.
51. Krowicki, K.; Lown, J.W. J. Org. Chem., 1987, 52, 3493
52. Lown, J W. in : Molecular Aspect of Anticancer Drug-DNA Interactions, Vol. I, Neidle, S.; Waring, M.J. Eds., Macmillan, London, 1993, p 322.
53. Lee, M.; Rhodes, A.L ; Wyatt, M.D.; Furrow, S.; Hartley, J.A. Anti-Cancer Drug Design, 1993, 8, 173
54. Wyatt, M.D , Lee, M.; Hartley, J.A Anti-Cancer Drug Design, 1997, 12, 49.
55. Lee, H H ; Boyd, M., Gravatt, G L ; Denny, W.A. Anti-Cancer Drug Design, 1991, 6, 501.
56. Baraldi, P G., Beria, I.; Cacciari, B.; Capolongo, L.; Cozzi, P.; Mongelli, N.; Romagnoli, R ; Spalluto, G. Bioorg. Med. Chem. Lett , 1996, 6, 1247
57. Baraldi, P.G.; Beria, I ; Cacciari, B ; Cozzi, P.; Franzetti, C.; Mongelli, N.; Romagnoli, R.; Spalluto, G. Bioorg. Med. Chem. Lett., 1996, 6, 1241.
58. Marchini, S.; Cozzi, P.; Beria, I ; Geroni, C ; Capolongo, L.; D'Incalci, M., Broggini, M. Anti-Cancer Drug Design, 1998, (3), in press
59. Wyatt, M D.; Garbiras, B J.; Haskell, M.K.; Lee, M ; Souhami, R.L.; Hartley, J.A. Anti- Cancer Drug Design, 1994, 9, 511
60. Bigioni, M.; Ciucci, A.; Palma, C.; Salvatore, M.; Manzini, S.; Animati, F.; Lombardi, P.; Pratesi, G ; Supino, R.; Zunino, F. Proc. Am Ass. Cancer Res. 1995, 36, 175.
61. Ciucci, A.; Manzini, S.; Lombardi, P.; Arcamone, F. Nucleic Acids Res., 1996, 24, 311.
62. Animati, F.; Lombardi, P ; Rossi, C.; Giannini, G.; Di Pietro, G.; Arcamone, F. Patent WO 94/20463, 1994.
63. Animati, F.; Arcamone, F.; Conte, M.R.; Felicetti, P ; Galeone, A ; Lombardi, P , Mayol, L.; Paloma, L G.; Rossi, C. J. Med Chem 1995, 38, 1140
64. Cozzi, P.; Beria, I.; Biasoli, G ; Caldarelli, M.; Capolongo, L.; D'Alessio, R.; Geroni, C.; Mazzini, S.; Ragg, E.; Rossi, C ; Mongelli., N. Bioorg. Med. Chem. Lett., 1997, 7, 2985.
65. Panthananickal, A ; Hansch, C. Leo, A. J. Med. Chem , 1978, 21, 16.
66. Brendel, M.; Ruhland, A. Mutation Res., 1984, 133, 51.
67. Sunters, A.; Springer, C.J., Bagshave, K.D.; Souhami, R L.; Hartley, J.A. Biochem., Pharmacol., 1992, 44, 59.
68. Cozzi, P.; Beria, I.; Biasoli, G.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli., N. Bioorg. Med. Chem Lett , 1997, 7, 2979.
69. Brooks, N.; Hartley, J-A.; Lee, M.; Centioni, S Proc Am Ass. Cancer Res. 1991, 38, 610.
70. Sigurdsson, S.T.; Hopkins, P.B Tetrahedron, 1994, 50, 12065.
71. Lee, M ; Simpson Jr. J-E.; Burns, A.J., Kupchinsky, S.; Brooks, N.; Hartley, J A; Kelland, L R. Med. Chem. Res., 1996, 365.
72. Xie, Y.; Miller, G.G.; Cubitt, S.A.; Soderlind, K.J.; Allalunis-Turner, M.J.; Lown, J.W. Anti-Cancer Drug Design, 1997, 12, 169.
73. Nicolau, K.C.; Dai, W-M. Angew. Chem., Int. Ed. 1991, 30, 1387.
74. Wittman, M.D.; Kadow, J.F.; Langley, D.R.; Vyas, D.M.; Rose, W.C.; Solomon, W.; Zein, N. Bioorg Med. Chem. Lett., 1995, 5, 1049.
75. Bailly, C.; Pommery, N.; Houssin, R.; Henichart, J-P. J. Pharm. Science, 1989, 78, 910.
76. Riou, J.F.; Grondard, L.; Naudin, A. Bailly, C. Biochem. Pharmacol., 1995, 50, 424.
77. Helissey, P.; Bailly, C.; Vishwakarma, J.N.; Auclair, C.; Waring, M J., Giorgi-Renault, S. Anti-Cancer Drug Design, 1996, 11, 527.
78. Barrows, L.R , Radisky, D C.; Copp, B.R.; Swaffar, D.S.; Kramer, R.A.; Warters, L.R., Ireland, C.M Anti-Cancer Drug Design, 1993, 8, 333
79. Zhao, R , Lown, J.W Heterocycles, 1995, 41, 337
80. Ahao, R., Oreski, B.; Lown, J W. Bioorg. Med. Chem. Lett , 1996, 6, 2169.
81. Boite, N.; Pommery, N.; Colson, P.; Houssier, C ; Waring, M.J.; Henichart, J-P.; Bailly, C. Anti-Cancer Drug Design, 1997, 12, 481
82. Bailly, C. ; Helbeque, N.; Henichart, J-P.; Colson, P.; Houssier, C.; Rao, C.; Shea, B.C.; Lown, J.W. J. Mol.Recognition, 1990, 3, 26.
83. Hartley, J.A; McAdam, S.R.; Das, S.; Roldan, M.C.; Haskell, M.K.; Lee, M. Anti-Cancer Drug Design, 1994, 9, 181
84. Gupta, R.; Al-Said, N.H.; Oreski, B ; Lown, J.W Anti-Cancer Drug Design ,1996, 11, 325
85. Zhao, R.; Al-Said, N.H.; Sternbach, D L.; Lown, J.W. J. Med. Chem 1997, 40, 216
86. Sondhi, S M ; Praveen Reddy, B.S., Lown, J.W Curr. Med. Chem. 1997, 4, 313.